Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Surface Ophthalmics logo — Developing Next Generation Therapies for Ocular Surface Dise...

Surface Ophthalmics

Developing Next Generation Therapies for Ocular Surface Diseases

Founded 2018 3 employees Venture round Biotechnology, Health Care +2

General Information

Company Name Surface Ophthalmics
Founded Year 2018
Employees 3
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Surface Ophthalmics. To contact Surface Ophthalmics, visit surfaceophthalmics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Surface Ophthalmics compare?

A PDF of Surface Ophthalmics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Surface Ophthalmics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Surface Ophthalmics

Surface Ophthalmics (Surface) is a biopharmaceutical firm founded in 2018, focusing on developing advanced therapies for ocular surface diseases. The company's mission is to address critical care needs within eye care by leveraging expertise, a dynamic strategy, efficiency, and clinical benefits. Surface is supported by a remarkable team of leaders and advisors, each distinguished by their outstanding leadership qualities, exceptional skills, and comprehensive industry knowledge—factors vital to the company’s achievements. The firm operates in the biotechnology, health care, health and wellness, and pharmaceutical industries. Despite the absence of specific details on the headquarters, their slogan "Developing Next Generation Therapies for Ocular Surface Diseases" underscores their commitment to innovation in the sector. As of now, there is no publicly disclosed information about their last investment or the involved investors. Surface Ophthalmics is a promising player in the field, with its focus on addressing unmet needs in ocular healthcare through cutting-edge therapies.

No funding data available for Surface Ophthalmics yet.

FAQ About Surface Ophthalmics

Developing Next Generation Therapies for Ocular Surface Diseases
Surface Ophthalmics was founded in 2018.
Surface Ophthalmics operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical.
Surface Ophthalmics has approximately 3 employees.

We're actively collecting intelligence on Surface Ophthalmics.

Source: BounceWatch company record for Surface Ophthalmics, https://bouncewatch.com/company/surface-ophthalmics, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes